Sep 14, 2023 / 12:20PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good afternoon, everyone. I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst from Bank of America, and welcome to our 2023 Global Healthcare Conference. Our next company up today live from London is Revvity. And with us is Max Krakowiak, CFO. Thanks, Max, for being here.
Maxwell Krakowiak - Revvity, Inc. - Senior VP & CFO
Yes. Thanks for having us.
Questions and Answers:
Derik De Bruin - BofA Securities, Research Division - MD of Equity ResearchWe'll have a shaft for a bit, and then we'll open the Q&A up to the audience. But I guess to kick off, it's been a year since you announced plans to transform PKI into Revvity and 1 quarter since the formal split. Certainly, given some of the slowdown we've seen in some of the traditional tools markets that the business you spread out the same. That seems like a really good idea. I guess that said, I still have a lot of clients asking who is Revvity. And can you
Trustpilot
